HCV genotyping using statistical classification approach
Open Access
- 1 January 2009
- journal article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 16 (1) , 62
- https://doi.org/10.1186/1423-0127-16-62
Abstract
The genotype of Hepatitis C Virus (HCV) strains is an important determinant of the severity and aggressiveness of liver infection as well as patient response to antiviral therapy. Fast and accurate determination of viral genotype could provide direction in the clinical management of patients with chronic HCV infections. Using publicly available HCV nucleotide sequences, we built a global Position Weight Matrix (PWM) for the HCV genome. Based on the PWM, a set of genotype specific nucleotide sequence "signatures" were selected from the 5' NCR, CORE, E1, and NS5B regions of the HCV genome. We evaluated the predictive power of these signatures for predicting the most common HCV genotypes and subtypes. We observed that nucleotide sequence signatures selected from NS5B and E1 regions generally demonstrated stronger discriminant power in differentiating major HCV genotypes and subtypes than that from 5' NCR and CORE regions. Two discriminant methods were used to build predictive models. Through 10 fold cross validation, over 99% prediction accuracy was achieved using both support vector machine (SVM) and random forest based classification methods in a dataset of 1134 sequences for NS5B and 947 sequences for E1. Prediction accuracy for each genotype is also reported.Keywords
This publication has 36 references indexed in Scilit:
- Early Changes in Hepatitis C Virus (HCV) Levels in Response to Peginterferon and Ribavirin Treatment in Patients with Chronic HCV Genotype 1 InfectionThe Journal of Infectious Diseases, 2009
- Chronic Hepatitis C and Genotyping: The Clinical Significance of Determining HCV GenotypesAntiviral Therapy, 2005
- Hepatitis C treatment updateThe American Journal of Medicine, 2004
- Understanding hepatitis C.2004
- Determining hepatitis C genotype by analyzing the sequence of the NS5b regionJournal of Virological Methods, 2003
- Clinical Significance of Hepatitis C Virus GenotypesClinical Microbiology Reviews, 2000
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groupsJournal of General Virology, 1995
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989